文献速递类风湿关节炎

从症状出现到类风湿关节炎:ACPA阳性与阴性病程轨迹是否相似?

Progression from symptom onset to rheumatoid arthritis: is the trajectory similar in anticitrullinated protein antibody-positive and -negative disease? A comparative longitudinal study.
PubMed 文献 · Ann Rheum Dis · 2026-05-27

该纵向比较研究纳入173例临床疑似关节痛并最终发展为类风湿关节炎(RA)的患者(ACPA阴性87例、阳性86例),比较从症状出现至疑似关节痛就诊、以及从就诊至RA发展的时限和炎症相关指标轨迹。结果显示ACPA阳性者症状至就诊时间更长但就诊至RA发展更短,ACPA阴性者晨僵和手部疼痛/压痛更突出,ACPA阳性者CRP和亚临床关节炎症(尤其前足)在RA发生前一年内上升更快。

要点

  • ACPA阳性者从症状出现到疑似关节痛就诊的时间更长,但从就诊到RA发展的时间更短。
  • ACPA阴性者在症状出现、就诊及至RA发展期间晨僵和手部疼痛/压痛更明显。
  • ACPA阳性者在RA发生前一年内CRP和亚临床关节炎症(尤其前足)上升更快。

核心结论

  • 从症状出现到RA发展,ACPA阴性与阳性患者在时间线、晨僵严重程度及手/足炎症部位上存在差异,可能反映不同的潜在炎症机制。

研究设计与样本

  • 纵向比较研究,纳入173例临床疑似关节痛并最终发展为RA的患者,其中ACPA阴性87例、ACPA阳性86例。
  • 比较从症状出现至疑似关节痛就诊、以及从就诊至RA发展的时限,并纵向评估临床、实验室和影像学炎症指标轨迹。

主要发现

  • ACPA阳性患者从症状出现到疑似关节痛就诊的时间更长(p=0.006),但从就诊到RA发展的时间更短(p=0.014)。
  • ACPA阴性患者在症状出现时(p=0.024)、疑似关节痛就诊时(p=0.006)及至RA发展期间(p=0.017)晨僵更严重。
  • ACPA阴性患者在症状出现时手部疼痛更多、就诊时(p<0.001)及至RA发展期间(p<0.001)手部压痛关节更多。
  • ACPA阳性患者在RA发生前一年内CRP水平上升更快(p=0.006),亚临床关节炎症增加更快,归因于前足炎症增加更显著(p=0.043)。

临床怎么用

  • 对于临床疑似关节痛患者,ACPA状态可能提示不同的前RA病程轨迹,ACPA阴性者以晨僵和手部症状更突出,ACPA阳性者炎症指标和亚临床炎症上升更快。
  • 这些差异可能提示ACPA阳性和阴性RA发展需要不同的预防策略。

局限性

  • 原文摘要未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The period between symptom onset and the development of rheumatoid arthritis (RA) is a putative window for disease modification. It is insufficiently known whether anticitrullinated protein antibody (ACPA)-positive and ACPA-negative disease develop similarly in this symptomatic pre-RA period. We therefore studied this trajectory in developing ACPA-positive and ACPA-negative RA and compared timelines and inflammation-related markers. METHODS: We studied 173 (n = 87 ACPA-negative and n = 86 ACPA-positive) patients with clinically suspected arthralgia (CSA) who all developed RA. Time from symptom onset to presentation with CSA, and from CSA presentation to RA development were compared. Longitudinal inflammatory trajectories were assessed by studying clinical measures (morning stiffness and tender joints), laboratory (C-reactive protein [CRP]), and imaging (hand/foot-magnetic resonance imaging) markers. RESULTS: ACPA-positive patients had a longer time between symptom onset and presentation with CSA, but a shorter time from CSA presentation until RA development (p = 0.006 and p = 0.014, respectively). ACPA-negative patients had more morning stiffness at symptom onset (p = 0.024), at CSA presentation (p = 0.006) and until RA development (p = 0.017). Likewise, ACPA-negative patients had more hand pain at symptom onset, more tender hand joints at CSA presentation (p < 0.001) and until RA development (p < 0.001). In contrast, ACPA-positive patients showed a faster increase in CRP level (p = 0.006) and subclinical joint inflammation the year before developing RA, which was due to a significantly greater increase in forefoot inflammation (p = 0.043). CONCLUSIONS: From symptom onset to RA development, ACPA-negative and ACPA-positive disease differ in timelines, morning stiffness severity, and location of inflammation in hands/feet. These differences may reflect differences in underlying inflammatory mechanisms and may suggest that different preventive strategies are required to intervene in the development of ACPA-positive and ACPA-negative RA.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Malekroudi MH, Claassen S, van Steenbergen HW, et al. Progression from symptom onset to rheumatoid arthritis: is the trajectory similar in anticitrullinated protein antibody-positive and -negative disease? A comparative longitudinal study. Ann Rheum Dis. 2026. PMID: 42203632. doi:10.1016/j.ard.2026.04.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。